273 related articles for article (PubMed ID: 30952158)
1. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
[TBL] [Abstract][Full Text] [Related]
2. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
Awab GR; Pukrittayakamee S; Imwong M; Dondorp AM; Woodrow CJ; Lee SJ; Day NP; Singhasivanon P; White NJ; Kaker F
Malar J; 2010 Apr; 9():105. PubMed ID: 20409302
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
[TBL] [Abstract][Full Text] [Related]
5. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Milligan R; Daher A; Graves PM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
[TBL] [Abstract][Full Text] [Related]
6. Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Sutanto I; Soebandrio A; Ekawati LL; Chand K; Noviyanti R; Satyagraha AW; Subekti D; Santy YW; Crenna-Darusallam C; Instiaty I; Budiman W; Prasetya CB; Lardo S; Elyazar I; Duparc S; Cedar E; Rolfe K; Fernando D; Berni A; Jones S; Kleim JP; Fletcher K; Sharma H; Martin A; Taylor M; Goyal N; Green JA; Tan LK; Baird JK
Lancet Infect Dis; 2023 Oct; 23(10):1153-1163. PubMed ID: 37236221
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.
Commons RJ; Simpson JA; Thriemer K; Abreha T; Adam I; Anstey NM; Assefa A; Awab GR; Baird JK; Barber BE; Chu CS; Dahal P; Daher A; Davis TME; Dondorp AM; Grigg MJ; Humphreys GS; Hwang J; Karunajeewa H; Laman M; Lidia K; Moore BR; Mueller I; Nosten F; Pasaribu AP; Pereira DB; Phyo AP; Poespoprodjo JR; Sibley CH; Stepniewska K; Sutanto I; Thwaites G; Hien TT; White NJ; William T; Woodrow CJ; Guerin PJ; Price RN
PLoS Med; 2019 Oct; 16(10):e1002928. PubMed ID: 31584960
[TBL] [Abstract][Full Text] [Related]
8. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
9. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Sutanto I; Tjahjono B; Basri H; Taylor WR; Putri FA; Meilia RA; Setiabudy R; Nurleila S; Ekawati LL; Elyazar I; Farrar J; Sudoyo H; Baird JK
Antimicrob Agents Chemother; 2013 Mar; 57(3):1128-35. PubMed ID: 23254437
[TBL] [Abstract][Full Text] [Related]
10. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
Pasaribu AP; Chokejindachai W; Sirivichayakul C; Tanomsing N; Chavez I; Tjitra E; Pasaribu S; Imwong M; White NJ; Dondorp AM
J Infect Dis; 2013 Dec; 208(11):1906-13. PubMed ID: 23926329
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Lwin KM; Win HH; San T; Aung AA; Raksapraidee R; Carrara VI; Bancone G; Watson J; Moore KA; Wiladphaingern J; Proux S; Sriprawat K; Winterberg M; Cheah PY; Chue AL; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2018 Oct; 67(10):1543-1549. PubMed ID: 29889239
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
Phyo AP; Lwin KM; Price RN; Ashley EA; Russell B; Sriprawat K; Lindegardh N; Singhasivanon P; White NJ; Nosten F
Clin Infect Dis; 2011 Nov; 53(10):977-84. PubMed ID: 22002979
[TBL] [Abstract][Full Text] [Related]
16. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
Galappaththy GN; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial.
Lon C; Manning JE; Vanachayangkul P; So M; Sea D; Se Y; Gosi P; Lanteri C; Chaorattanakawee S; Sriwichai S; Chann S; Kuntawunginn W; Buathong N; Nou S; Walsh DS; Tyner SD; Juliano JJ; Lin J; Spring M; Bethell D; Kaewkungwal J; Tang D; Chuor CM; Satharath P; Saunders D
PLoS One; 2014; 9(3):e93138. PubMed ID: 24667662
[TBL] [Abstract][Full Text] [Related]
18. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
[TBL] [Abstract][Full Text] [Related]
19. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Sinclair D; Gogtay N; Brand F; Olliaro P
Cochrane Database Syst Rev; 2011 Jul; (7):CD008492. PubMed ID: 21735431
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic and Transmission-Blocking
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia.
Popovici J; Vantaux A; Primault L; Samreth R; Piv EP; Bin S; Kim S; Lek D; Serre D; Menard D
Emerg Infect Dis; 2018 Aug; 24(8):1516-1519. PubMed ID: 29798745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
